Dr. Reddy's Laboratories launches Ezetimibe & Simvastatin Tablets in the US Market

27 Apr 2017 Evaluate

Dr. Reddys Laboratories has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg a therapeutic equivalent generic version of Vytorin (Ezetimibe and Simvastatin) Tablets in the United States market, approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's is among the first companies to launch the generic product in the U.S. market.

The Vytorin brand had U.S. sales of approximately $678 million MAT for the most recent twelve months ended in February 2017 according to IMS Health.  Dr. Reddy's Ezetimibe and Simvastatin Tablets are available in bottle count sizes of 30, 90 and 1000. Vytorin is a registered trademark of MSD International GmbH.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1293.00 -25.75 (-1.95%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×